TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

Researchers believe endoglin (ENG), with its capacity to deliver comprehensive tumor targeting, could advance the use of chimeric antigen receptor (CAR) T-cell therapy to treat advanced sarcomas....

Researchers hope their novel but simple approach to rapid expansion of homogenous human type II innate lymphoid cells (ILC2) provides another option for preventing or treating graft-versus-host...

Research shows that ixazomib prevents development of moderate/severe chronic graft-versus-host disease (cGVHD), a complication of allogeneic transplantation (allo-HSCT) that investigators say can...

Among children with thalassemia major, researchers say treosulfan-based conditioning prepares them for hematopoietic stem cell transplantation (allo-HSCT) without harming their natural growth...

Scientists say myeloid-derived suppressor cells (MDSCs) engineered with human induced pluripotent stem cells (iPSC) may hold the key to migrating off-the-shelf MDSCs to the clinical setting, where...

Tumor-specific antigens remain elusive in T-cell lymphomas (TCL), effectively limiting the impact of chimeric antigen receptor (CAR) T-cell therapy in this setting, but scientists are encouraged...